In addition, the inhibition of ERK1/2 by PD98059 significantly decreased CRC cell migration in both wound healing and transwell migration assays (Figure 4D and 4E), and decreased cell invasion in the transwell invasion assay (Figure 4F). The gene discussed is MAPK3; the disease is colorectal carcinoma.